150 related articles for article (PubMed ID: 8780719)
1. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer.
Miwa W; Yasuda J; Murakami Y; Yashima K; Sugano K; Sekine T; Kono A; Egawa S; Yamaguchi K; Hayashizaki Y; Sekiya T
Biochem Biophys Res Commun; 1996 Aug; 225(3):968-74. PubMed ID: 8780719
[TBL] [Abstract][Full Text] [Related]
2. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas.
Ruggeri BA; Huang L; Wood M; Cheng JQ; Testa JR
Mol Carcinog; 1998 Feb; 21(2):81-6. PubMed ID: 9496907
[TBL] [Abstract][Full Text] [Related]
3. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines.
Tang TC; Sham JS; Xie D; Fang Y; Huo KK; Wu QL; Guan XY
Cancer Res; 2002 Dec; 62(24):7157-61. PubMed ID: 12499249
[TBL] [Abstract][Full Text] [Related]
4. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.
Cheng JQ; Ruggeri B; Klein WM; Sonoda G; Altomare DA; Watson DK; Testa JR
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3636-41. PubMed ID: 8622988
[TBL] [Abstract][Full Text] [Related]
5. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.
Cheng JQ; Godwin AK; Bellacosa A; Taguchi T; Franke TF; Hamilton TC; Tsichlis PN; Testa JR
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9267-71. PubMed ID: 1409633
[TBL] [Abstract][Full Text] [Related]
6. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines.
Curtis LJ; Li Y; Gerbault-Seureau M; Kuick R; Dutrillaux AM; Goubin G; Fawcett J; Cram S; Dutrillaux B; Hanash S; Muleris M
Genomics; 1998 Oct; 53(1):42-55. PubMed ID: 9787076
[TBL] [Abstract][Full Text] [Related]
7. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene.
Wallrapp C; Müller-Pillasch F; Solinas-Toldo S; Lichter P; Friess H; Büchler M; Fink T; Adler G; Gress TM
Cancer Res; 1997 Aug; 57(15):3135-9. PubMed ID: 9242439
[TBL] [Abstract][Full Text] [Related]
9. Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2.
Mitsuuchi Y; Johnson SW; Sonoda G; Tanno S; Golemis EA; Testa JR
Oncogene; 1999 Sep; 18(35):4891-8. PubMed ID: 10490823
[TBL] [Abstract][Full Text] [Related]
10. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines.
Sen S; Zhou H; White RA
Oncogene; 1997 May; 14(18):2195-200. PubMed ID: 9174055
[TBL] [Abstract][Full Text] [Related]
11. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies.
Thompson FH; Nelson MA; Trent JM; Guan XY; Liu Y; Yang JM; Emerson J; Adair L; Wymer J; Balfour C; Massey K; Weinstein R; Alberts DS; Taetle R
Cancer Genet Cytogenet; 1996 Mar; 87(1):55-62. PubMed ID: 8646743
[TBL] [Abstract][Full Text] [Related]
12. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
Bellacosa A; de Feo D; Godwin AK; Bell DW; Cheng JQ; Altomare DA; Wan M; Dubeau L; Scambia G; Masciullo V; Ferrandina G; Benedetti Panici P; Mancuso S; Neri G; Testa JR
Int J Cancer; 1995 Aug; 64(4):280-5. PubMed ID: 7657393
[TBL] [Abstract][Full Text] [Related]
13. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.
Altomare DA; Guo K; Cheng JQ; Sonoda G; Walsh K; Testa JR
Oncogene; 1995 Sep; 11(6):1055-60. PubMed ID: 7566964
[TBL] [Abstract][Full Text] [Related]
14. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
15. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines.
Yang ZQ; Imoto I; Fukuda Y; Pimkhaokham A; Shimada Y; Imamura M; Sugano S; Nakamura Y; Inazawa J
Cancer Res; 2000 Sep; 60(17):4735-9. PubMed ID: 10987278
[TBL] [Abstract][Full Text] [Related]
17. Chromosome mapping of the mouse Akt2 gene and Akt2 pseudogene.
Altomare DA; Kozak CA; Sonoda G; Testa JR
Cytogenet Cell Genet; 1996; 74(4):248-51. PubMed ID: 8976376
[TBL] [Abstract][Full Text] [Related]
18. Identification of the TCL1/MTCP1-like 1 (TML1) gene from the region next to the TCL1 locus.
Sugimoto J; Hatakeyama T; Narducci MG; Russo G; Isobe M
Cancer Res; 1999 May; 59(10):2313-7. PubMed ID: 10344735
[TBL] [Abstract][Full Text] [Related]
19. GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers.
Saint-Ruf C; Malfoy B; Scholl S; Zafrani B; Dutrillaux B
Oncogene; 1991 Mar; 6(3):403-6. PubMed ID: 1826346
[TBL] [Abstract][Full Text] [Related]
20. An integrated high-resolution physical map of the DPC/BRCA2 region at chromosome 13q12.
Schutte M; Rozenblum E; Moskaluk CA; Guan X; Hoque AT; Hahn SA; da Costa LT; de Jong PJ; Kern SE
Cancer Res; 1995 Oct; 55(20):4570-4. PubMed ID: 7553631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
